Livermore

RP Management, LLC

SEC CIK
0001507673

Holdings, Q2 2025

Positions as of Jun 30, 2025, filed Aug 6, 2025.SEC

Positions
0
−4 vs. Q1 2025
Total value
$0
−$138.84M (−100.0%) vs. Q1 2025

Compare with Q1 2025: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q1 2025.

RP Management, LLC holdings in Q2 2025
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
No long positions in this filing.

Sold out since Q1 2025 (4)

Positions held at the end of Q1 2025 that are no longer in this filing.

RP Management, LLC positions sold out since Q1 2025
SecurityClassShares, Q1 2025Value, Q1 2025% of portfolio, Q1 2025
BHVNBIOHAVEN LTDCOM2,936,507$70.59M50.84%
CYTKCYTOKINETICS INCCOM NEW980,392$39.4M28.38%
BCRXBIOCRYST PHARMACEUTICALS INCCOM3,846,154$28.85M20.78%
VIRACTA THERAPEUTICS INC92765F108COM3,700$740.00%

13F filings by quarter

RP Management, LLC 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q2 2025Aug 6, 20250$0vs. Q1 2025SEC
Q1 2025May 2, 20254$138.84Mvs. Q4 2024SEC
Q4 2024Feb 3, 20254$227.73Mvs. Q3 2024SEC
Q3 2024Nov 13, 20244$227.73Mvs. Q2 2024SEC
Q2 2024Aug 13, 20244$178.82Mvs. Q1 2024SEC
Q1 2024May 8, 20243$180.14Mvs. Q4 2023SEC
Q4 2023Feb 13, 20243$148.72Mvs. Q3 2023SEC
Q3 2023Nov 13, 20233$103.61Mvs. Q2 2023SEC
Q2 2023Aug 11, 20233$97.32Mvs. Q1 2023SEC
Q1 2023May 15, 20233$72.2Mvs. Q4 2022SEC
Q4 2022Feb 14, 20233$84.92Mvs. Q3 2022SEC
Q3 2022Nov 14, 20223$216.45Mvs. Q2 2022SEC
Q2 2022Aug 10, 20224$249.42Mvs. Q1 2022SEC
Q1 2022May 11, 20224$242.05Mvs. Q4 2021SEC
Q4 2021Feb 14, 20224$232.54Mvs. Q3 2021SEC
Q3 2021Nov 15, 20213$201.31Mvs. Q2 2021SEC
Q2 2021Aug 12, 20213$184.08Mvs. Q1 2021SEC
Q1 2021May 17, 20214$244.54M–SEC